Bronchitol — Medical Mutual
Cystic Fibrosis
Initial criteria
- Patient is age ≥ 18 years; AND
 - Patient has tried hypertonic saline; AND
 - Patient has passed the Bronchitol Tolerance Test; AND
 - Patient will pre-medicate with a short-acting bronchodilator; AND
 - Medication is prescribed by or in consultation with a pulmonologist or a physician who specializes in the treatment of cystic fibrosis; AND
 - Medication is used as add-on maintenance therapy to improve pulmonary function
 
Reauthorization criteria
- Patient is age ≥ 18 years; AND
 - Patient has tried hypertonic saline; AND
 - Patient has passed the Bronchitol Tolerance Test; AND
 - Patient will pre-medicate with a short-acting bronchodilator; AND
 - Medication is prescribed by or in consultation with a pulmonologist or a physician who specializes in the treatment of cystic fibrosis; AND
 - Medication is used as add-on maintenance therapy to improve pulmonary function; AND
 - Patient has experienced an adequate response to therapy, as evidenced by improvement in FEV1 and/or other lung function tests per the prescribing physician
 
Approval duration
365 days